Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Selective serotonin reuptake inhibitor treatment retunes emotional valence in primate ventral striatum


Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat psychiatric disorders with affective biases such as depression and anxiety. How SSRIs exert a beneficial action on emotions associated with life events is still unknown. Here we ask whether and how the effectiveness of the SSRI fluoxetine is underpinned by neural mechanisms in the ventral striatum. To address these issues, we studied the spiking activity of neurons in the ventral striatum of monkeys during an approach-avoidance task in which the valence assigned to sensory stimuli was manipulated. Neural responses to positive and negative events were measured before and during a 4-week treatment with fluoxetine. We conducted PET scans to confirm that fluoxetine binds within the ventral striatum at a therapeutic dose. In our monkeys, fluoxetine facilitated approach of rewards and avoidance of punishments. These beneficial effects were associated with changes in tonic and phasic activities of striatal neurons. Fluoxetine increased the spontaneous firing rate of striatal neurons and amplified the number of cells responding to rewards versus punishments, reflecting a drug-induced positive shift in the processing of emotionally valenced information. These findings reveal how SSRI treatment affects ventral striatum neurons encoding positive and negative valence and striatal signaling of emotional information. In addition to a key role in appetitive processing, our results shed light on the involvement of the ventral striatum in aversive processing. Together, the ventral striatum appears to play a central role in the action of SSRIs on emotion processing biases commonly observed in psychiatric disorders.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Approach-avoidance task and behavior.
Fig. 2: Fluoxetine effects in the ventral striatum.
Fig. 3: Two types of valence-discriminating neurons.
Fig. 4: Fluoxetine effects on valence-encoding cells.


  1. 1.

    Artigas F, Romero L, de Montigny C, Blier P. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci. 1996;19:378–83.

    CAS  PubMed  Google Scholar 

  2. 2.

    Maya Vetencourt JF, Sale A, Viegi A, Baroncelli L, De Pasquale R, O’Leary OF, et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science. 2008;320:385–8.

    CAS  PubMed  Google Scholar 

  3. 3.

    Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003;301:805–9.

    CAS  PubMed  Google Scholar 

  4. 4.

    Warren MB, Pringle A, Harmer CJ. A neurocognitive model for understanding treatment action in depression. Philos Trans R Soc Lond B Biol Sci. 2015;370:20140213.

    PubMed  PubMed Central  Google Scholar 

  5. 5.

    Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry. 2017;4:409–18.

    PubMed  PubMed Central  Google Scholar 

  6. 6.

    Roiser JP, Elliott R, Sahakian BJ. Cognitive mechanisms of treatment in depression. Neuropsychopharmacology. 2012;37:117–36.

    CAS  PubMed  Google Scholar 

  7. 7.

    Harmer CJ, Bhagwagar Z, Perrett DI, Völlm BA, Cowen PJ, Goodwin GM. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology. 2003;28:148–52.

    CAS  PubMed  Google Scholar 

  8. 8.

    Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry. 2006;59:816–20.

    CAS  PubMed  Google Scholar 

  9. 9.

    Harmer CJ, O’Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A, et al. Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry. 2009;166:1178–84.

    PubMed  Google Scholar 

  10. 10.

    Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry. 2004;161:1256–63.

    PubMed  Google Scholar 

  11. 11.

    Shiroma PR, Thuras P, Johns B, Lim KO. Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression. Int J Geriatr Psychiatry. 2014;29:1132–9.

    PubMed  Google Scholar 

  12. 12.

    Harmer CJ, Rogers RD, Tunbridge E, Cowen PJ, Goodwin GM. Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology. 2003;167:411–7.

    CAS  PubMed  Google Scholar 

  13. 13.

    Tranter R, Bell D, Gutting P, Harmer C, Healy D, Anderson IM. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients. J Affect Disord. 2009;118:87–93.

    CAS  PubMed  Google Scholar 

  14. 14.

    Bigos KL, Pollock BG, Aizenstein HJ, Fisher PM, Bies RR, Hariri AR. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology. 2008;33:3221–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Del-Ben CM, Deakin JFW, McKie S, Delvai NA, Williams SR, Elliott R, et al. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology. 2005;30:1724–34.

    CAS  PubMed  Google Scholar 

  16. 16.

    Murphy SE, Norbury R, O’Sullivan U, Cowen PJ, Harmer CJ. Effect of a single dose of citalopram on amygdala response to emotional faces. Br J Psychiatry J Ment Sci. 2009;194:535–40.

    Google Scholar 

  17. 17.

    Outhred T, Das P, Felmingham KL, Bryant RA, Nathan PJ, Malhi GS, et al. Impact of acute administration of escitalopram on the processing of emotional and neutral images: a randomized crossover fMRI study of healthy women. J Psychiatry Neurosci. 2014;39:267–75.

    PubMed  PubMed Central  Google Scholar 

  18. 18.

    Brühl AB, Jäncke L, Herwig U. Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants. Psychopharmacology. 2011;216:389–99.

    PubMed  Google Scholar 

  19. 19.

    Brühl AB, Kaffenberger T, Herwig U. Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants. Neuropsychopharmacology. 2010;35:521–33.

    PubMed  Google Scholar 

  20. 20.

    Ma Y. Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis. Mol Psychiatry. 2015;20:311–9.

    CAS  Google Scholar 

  21. 21.

    Simmons AN, Arce E, Lovero KL, Stein MB, Paulus MP. Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers. Int J Neuropsychopharmacol. 2009;12:1009–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Vai B, Bulgarelli C, Godlewska BR, Cowen PJ, Benedetti F, Harmer CJ. Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration. Eur Neuropsychopharmacology. 2016;26:2000–10.

    CAS  Google Scholar 

  23. 23.

    Choi EY, Ding S-L, Haber SN. Combinatorial Inputs to the ventral striatum from the temporal cortex, frontal cortex, and amygdala: implications for segmenting the striatum. ENeuro. 2017;4.

  24. 24.

    Pohlack ST, Nees F, Ruttorf M, Schad LR, Flor H. Activation of the ventral striatum during aversive contextual conditioning in humans. Biol Psychol. 2012;91:74–80.

    PubMed  Google Scholar 

  25. 25.

    Jensen J, McIntosh AR, Crawley AP, Mikulis DJ, Remington G, Kapur S. Direct activation of the ventral striatum in anticipation of aversive stimuli. Neuron. 2003;40:1251–7.

    CAS  PubMed  Google Scholar 

  26. 26.

    Van Bockstaele EJ, Biswas A, Pickel VM. Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens. Brain Res. 1993;624:188–98.

    PubMed  Google Scholar 

  27. 27.

    Parent A, Mackey A, De, Bellefeuille L. The subcortical afferents to caudate nucleus and putamen in primate: a fluorescence retrograde double labeling study. Neuroscience. 1983;10:1137–50.

    CAS  PubMed  Google Scholar 

  28. 28.

    Beliveau V, Ganz M, Feng L, Ozenne B, Højgaard L, Fisher PM, et al. A high-resolution in vivo atlas of the human brain’s serotonin system. J Neurosci J Soc Neurosci. 2017;37:120–8.

    CAS  Google Scholar 

  29. 29.

    Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2010;35:4–26.

    PubMed  Google Scholar 

  30. 30.

    Schultz W. Reward functions of the basal ganglia. J Neural Transm. 2016;123:679–93.

    PubMed  Google Scholar 

  31. 31.

    Saga Y, Ruff CC, Tremblay L. Disturbance of approach-avoidance behaviors in non-human primates by stimulation of the limbic territories of basal ganglia and anterior insula. Eur J Neurosci. 2019;49:687–700.

    PubMed  Google Scholar 

  32. 32.

    Worbe Y, Baup N, Grabli D, Chaigneau M, Mounayar S, McCairn K, et al. Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum. Cereb Cortex. 2009;19:1844–56.

  33. 33.

    Worbe Y, Epinat J, Féger J, Tremblay L. Discontinuous long-train stimulation in the anterior striatum in monkeys induces abnormal behavioral states. Cereb Cortex. 2011;21:2733–41.

    PubMed  Google Scholar 

  34. 34.

    Tremblay L, Worbe Y, Thobois S, Sgambato-Faure V, Féger J. Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders. Mov Disord. 2015;30:1155–70.

    PubMed  Google Scholar 

  35. 35.

    Sgambato-Faure V, Worbe Y, Epinat J, Féger J, Tremblay L. Cortico-basal ganglia circuits involved in different motivation disorders in non-human primates. Brain Struct Funct. 2016;221:345–64.

    PubMed  Google Scholar 

  36. 36.

    Saga Y, Richard A, Sgambato-Faure V, Hoshi E, Tobler PN, Tremblay L. Ventral pallidum encodes contextual information and controls aversive behaviors. Cereb Cortex. 2017;27:2528–43.

    PubMed  Google Scholar 

  37. 37.

    Fontenot MB, Padgett EE, Dupuy AM, Lynch CR, De Petrillo PB, Higley JD. The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques. Comp Med. 2005;55:67–74.

    CAS  PubMed  Google Scholar 

  38. 38.

    Fontenot MB, Musso MW, McFatter RM, Anderson GM. Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta). J Am Assoc Lab Anim Sci. 2009;48:176–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Adler A, Katabi S, Finkes I, Prut Y, Bergman H. Different correlation patterns of cholinergic and GABAergic interneurons with striatal projection neurons. Front Syst Neurosci. 2013;7:47.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. 40.

    Joshua M, Adler A, Mitelman R, Vaadia E, Bergman H. Midbrain dopaminergic neurons and striatal cholinergic interneurons encode the difference between reward and aversive events at different epochs of probabilistic classical conditioning trials. J Neurosci. 2008;28:11673–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Berke JD, Okatan M, Skurski J, Eichenbaum HB. Oscillatory entrainment of striatal neurons in freely moving rats. Neuron. 2004;43:883–96.

    CAS  PubMed  Google Scholar 

  42. 42.

    Golub MS, Hogrefe CE, Sherwood RJ, Turck CW. Fluoxetine administration in juvenile monkeys: implications for pharmacotherapy in children. Front Pediatr. 2018;6:21.

    PubMed  PubMed Central  Google Scholar 

  43. 43.

    Beaudoin-Gobert M, Epinat J, Météreau E, Duperrier S, Neumane S, Ballanger B, et al. Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate. Brain J Neurol. 2015;138:2632–47.

    Google Scholar 

  44. 44.

    Millot M, Saga Y, Duperrier S, Météreau E, Beaudoin-Gobert M, Sgambato V. Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys. Neurobiol Dis. 2020;134:104643.

    CAS  PubMed  Google Scholar 

  45. 45.

    Ballanger B, Tremblay L, Sgambato-Faure V, Beaudoin-Gobert M, Lavenne F, Le Bars D, et al. A multi-atlas based method for automated anatomical Macaca fascicularis brain MRI segmentation and PET kinetic extraction. NeuroImage. 2013;77:26–43.

    PubMed  Google Scholar 

  46. 46.

    Pasquereau B, Turner RS. Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons. Cereb Cortex. 2011;21:1362–78.

    PubMed  Google Scholar 

  47. 47.

    Bradley BP, Mogg K, Williams R. Implicit and explicit memory for emotion-congruent information in clinical depression and anxiety. Behav Res Ther. 1995;33:755–70.

    CAS  PubMed  Google Scholar 

  48. 48.

    Heuer K, Rinck M, Becker ES. Avoidance of emotional facial expressions in social anxiety: The Approach-Avoidance Task. Behav Res Ther. 2007;45:2990–3001.

    PubMed  Google Scholar 

  49. 49.

    Vrijsen JN, van Oostrom I, Speckens A, Becker ES, Rinck M. Approach and avoidance of emotional faces in happy and sad mood. Cogn Ther Res. 2013;37:1–6.

    Google Scholar 

  50. 50.

    Bourke C, Douglas K, Porter R. Processing of facial emotion expression in major depression: a review. Aust N Z J Psychiatry. 2010;44:681–96.

    PubMed  Google Scholar 

  51. 51.

    Carlisi CO, Robinson OJ. The role of prefrontal-subcortical circuitry in negative bias in anxiety: Translational, developmental and treatment perspectives. Brain Neurosci Adv. 2018;2:2398212818774223.

    PubMed  PubMed Central  Google Scholar 

  52. 52.

    Bouhuys AL, Geerts E, Gordijn MC. Depressed patients’ perceptions of facial emotions in depressed and remitted states are associated with relapse: a longitudinal study. J Nerv Ment Dis. 1999;187:595–602.

    CAS  PubMed  Google Scholar 

  53. 53.

    Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. 13. Guilford Press: New York; 1979.

  54. 54.

    Fava M. Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment. J Clin Psychiatry. 2003;64:30–34.

    PubMed  Google Scholar 

  55. 55.

    Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28–40.

    PubMed  Google Scholar 

  56. 56.

    Anderson IM, Del-Ben CM, Mckie S, Richardson P, Williams SR, Elliott R, et al. Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. Neuroreport. 2007;18:1351–5.

    CAS  PubMed  Google Scholar 

  57. 57.

    Fu CHY, Williams SCR, Cleare AJ, Brammer MJ, Walsh ND, Kim J, et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry. 2004;61:877–89.

    PubMed  Google Scholar 

  58. 58.

    Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry. 2001;50:651–8.

    CAS  PubMed  Google Scholar 

  59. 59.

    Chen C-H, Suckling J, Ooi C, Fu CHY, Williams SCR, Walsh ND, et al. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology. 2008;33:1909–18.

    CAS  PubMed  Google Scholar 

  60. 60.

    Stoy M, Schlagenhauf F, Sterzer P, Bermpohl F, Hägele C, Suchotzki K, et al. Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram. J Psychopharmacol. 2012;26:677–88.

    PubMed  Google Scholar 

  61. 61.

    Ossewaarde L, Verkes RJ, Hermans EJ, Kooijman SC, Urner M, Tendolkar I, et al. Two-week administration of the combined serotonin-noradrenaline reuptake inhibitor duloxetine augments functioning of mesolimbic incentive processing circuits. Biol Psychiatry. 2011;70:568–74.

    CAS  PubMed  Google Scholar 

  62. 62.

    McCabe C, Mishor Z, Cowen PJ, Harmer CJ. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry. 2010;67:439–45.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. 63.

    Heller AS, Johnstone T, Light SN, Peterson MJ, Kolden GG, Kalin NH, et al. Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment. Am J Psychiatry. 2013;170:197–206.

    PubMed  PubMed Central  Google Scholar 

  64. 64.

    Takamura M, Okamoto Y, Okada G, Toki S, Yamamoto T, Ichikawa N, et al. Patients with major depressive disorder exhibit reduced reward size coding in the striatum. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79:317–23.

    PubMed  Google Scholar 

  65. 65.

    Bissonette GB, Burton AC, Gentry RN, Goldstein BL, Hearn TN, Barnett BR, et al. Separate populations of neurons in ventral striatum encode value and motivation. PLoS ONE. 2013;8:e64673.

    CAS  PubMed  PubMed Central  Google Scholar 

  66. 66.

    Reynolds SM, Berridge KC. Emotional environments retune the valence of appetitive versus fearful functions in nucleus accumbens. Nat Neurosci. 2008;11:423–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  67. 67.

    Ironside M, Amemori K-I, McGrath CL, Pedersen ML, Kang MS, Amemori S, et al. Approach-avoidance conflict in major depressive disorder: congruent neural findings in humans and nonhuman primates. Biol Psychiatry. 2020;87:399–408.

    PubMed  Google Scholar 

  68. 68.

    Tye KM, Deisseroth K. Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat Rev Neurosci. 2012;13:251–66.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. 69.

    Sgambato-Faure V, Tremblay L. Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states. J Neural Transm 2018;125:485–500.

    CAS  PubMed  Google Scholar 

  70. 70.

    Amemori K-I, Amemori S, Gibson DJ, Graybiel AM. Striatal microstimulation induces persistent and repetitive negative decision-making predicted by striatal beta-band oscillation. Neuron. 2018;99:829–41.e6.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references


We are grateful to Robert S. Turner and Sylvia Wirth for helpful comments on the manuscript.

Author information




LT, PNT and VS designed the study. GD, YS and AR collected the electrophysiological data. MM and EM collected and processed imaging data. BP was primary analyzer of the data and writer of the manuscript.

Corresponding author

Correspondence to Benjamin Pasquereau.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pasquereau, B., Drui, G., Saga, Y. et al. Selective serotonin reuptake inhibitor treatment retunes emotional valence in primate ventral striatum. Neuropsychopharmacol. (2021).

Download citation

Further reading


Quick links